Birdwatch Note
2023-12-03 00:55:33 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
アメリカにおける医薬品の売上ランキングにも抗がん剤が上位に3つ確認出来ます https://www.drugdiscoverytrends.com/50-of-2021s-best-selling-pharmaceuticals/ WHOも抗がん剤の使用を治療の選択肢として提案しています https://www.who.int/health-topics/cancer#tab=tab_3 このような事実と異なる情報の発信はがん治療の妨げになる場合もあり、命を奪いかねない大変重大な事態に陥る事があります がん治療における判断は出処不明の情報を安易に信じるのでは無く、必ず専門の医師と相談の上で行うようにしてください がん治療を行っている医師、看護師、薬剤師等について調べたいのであれば国立がん研究センターのがん情報サービスなどの信頼性の高い情報を利用してください https://ganjoho.jp/public/index.html 参考 https://news.yahoo.co.jp/expert/articles/1b191a2ed5889e97d4311826f130aa016629b2a8
Written by 851C0823716A3749AE190199EE2E79832D8254BAB5E0D7A93B6A994A5C1FC51E
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1730724974611374277
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1731114916063658362
- noteId - 1731114916063658362
- participantId -
- noteAuthorParticipantId - 851C0823716A3749AE190199EE2E79832D8254BAB5E0D7A93B6A994A5C1FC51E Participant Details
- createdAtMillis - 1701564933206
- tweetId - 1730724974611374277
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- アメリカにおける医薬品の売上ランキングにも抗がん剤が上位に3つ確認出来ます https://www.drugdiscoverytrends.com/50-of-2021s-best-selling-pharmaceuticals/ WHOも抗がん剤の使用を治療の選択肢として提案しています https://www.who.int/health-topics/cancer#tab=tab_3 このような事実と異なる情報の発信はがん治療の妨げになる場合もあり、命を奪いかねない大変重大な事態に陥る事があります がん治療における判断は出処不明の情報を安易に信じるのでは無く、必ず専門の医師と相談の上で行うようにしてください がん治療を行っている医師、看護師、薬剤師等について調べたいのであれば国立がん研究センターのがん情報サービスなどの信頼性の高い情報を利用してください https://ganjoho.jp/public/index.html 参考 https://news.yahoo.co.jp/expert/articles/1b191a2ed5889e97d4311826f130aa016629b2a8
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-12-03 00:55:33 UTC (1701564933206) |
1969-12-31 23:59:59 UTC (-1) |
2023-12-03 04:27:56 UTC (1701577676238) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-12-02 19:16:28 -0600 | Rating Details | |
| 2023-12-02 19:14:31 -0600 | Rating Details | |
| 2023-12-03 18:26:42 -0600 | Rating Details | |
| 2023-12-03 04:33:14 -0600 | Rating Details | |
| 2023-12-03 04:24:39 -0600 | Rating Details | |
| 2023-12-03 03:03:16 -0600 | Rating Details | |
| 2023-12-03 00:51:59 -0600 | Rating Details | |
| 2023-12-02 23:48:59 -0600 | Rating Details | |
| 2023-12-02 22:20:26 -0600 | Rating Details | |
| 2023-12-02 21:56:30 -0600 | Rating Details | |
| 2023-12-02 20:39:31 -0600 | Rating Details | |
| 2023-12-02 20:24:36 -0600 | Rating Details | |
| 2023-12-02 20:20:21 -0600 | Rating Details | |
| 2023-12-02 19:51:13 -0600 | Rating Details | |
| 2023-12-02 19:37:24 -0600 | Rating Details | |
| 2023-12-02 19:36:39 -0600 | Rating Details | |
| 2023-12-04 00:00:39 -0600 | Rating Details | |
| 2023-12-03 16:17:07 -0600 | Rating Details | |
| 2023-12-03 11:46:07 -0600 | Rating Details | |
| 2023-12-03 06:31:03 -0600 | Rating Details | |
| 2023-12-03 03:17:53 -0600 | Rating Details | |
| 2023-12-03 01:30:16 -0600 | Rating Details | |
| 2023-12-02 23:57:00 -0600 | Rating Details | |
| 2023-12-02 23:35:04 -0600 | Rating Details | |
| 2023-12-02 23:04:00 -0600 | Rating Details | |
| 2023-12-02 22:16:10 -0600 | Rating Details | |
| 2023-12-02 21:41:37 -0600 | Rating Details | |
| 2023-12-02 21:09:45 -0600 | Rating Details | |
| 2023-12-02 20:58:01 -0600 | Rating Details | |
| 2023-12-02 20:54:12 -0600 | Rating Details | |
| 2023-12-02 20:36:00 -0600 | Rating Details | |
| 2023-12-02 20:15:20 -0600 | Rating Details | |
| 2023-12-02 20:04:22 -0600 | Rating Details | |
| 2023-12-02 19:24:13 -0600 | Rating Details | |
| 2023-12-02 22:13:04 -0600 | Rating Details | |
| 2023-12-02 21:21:09 -0600 | Rating Details |